Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation

Clinical trial NCT03856216 · TERMINATED

Trial details

NCT number: NCT03856216
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia Lymphocytic Neoplasm Lymphoma

Start date: 2019-10-28
Primary completion: 2025-10-13
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.